ADAPTIMMUNE THERAPEUTICS PLC Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ADAPTIMMUNE THERAPEUTICS PLC stock issued during period, value, new issues for the quarter ending 2023-09-30 was $435.00K, a 69.92% decline year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC stock issued during period, value, new issues for the quarter ending 2023-03-31 was $188.00K.
- ADAPTIMMUNE THERAPEUTICS PLC stock issued during period, value, new issues for the quarter ending 2022-09-30 was $1.45M, a 14360.00% increase year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC stock issued during period, value, new issues for the quarter ending 2022-06-30 was $9.98M, a 296.03% increase year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC stock issued during period, value, new issues for fiscal 2018 was $99.65M, a 3.41% decline from fiscal 2017.
- ADAPTIMMUNE THERAPEUTICS PLC stock issued during period, value, new issues for fiscal 2017 was $103.17M.
- ADAPTIMMUNE THERAPEUTICS PLC stock issued during period, value, new issues for fiscal 2014 was $15.81M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2023-09-30 | $435.00K 10-Q · filed 2023-11-08 | |
| 2023-03-31 | $188.00K 10-Q · filed 2024-11-13 | |
| 2022-09-30 | $1.45M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $9.98M 10-Q · filed 2023-08-09 | |
| 2021-09-30 | $10.00K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $2.52M 10-Q · filed 2022-11-08 | |
| 2020-06-30 | $243.84M 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $90.55M 10-Q · filed 2021-11-04 | |
| 2018-12-31 | $99.65M 10-K · filed 2021-02-25 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $103.17M 10-K · filed 2019-02-27 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | |
| 2014-06-30 | $15.81M 10-K · filed 2017-03-13 | |
| 2013-06-30 | $6.60M 8-K · filed 2016-07-08 |